Global Perfusion Systems Market to Reach $1.5 Billion by 2030
The global market for Perfusion Systems estimated at US$1 Billion in the year 2022, is projected to reach a revised size of US$1.5 Billion by 2030, growing at a CAGR of 4.3% over the analysis period 2022-2030. Cardiopulmonary Perfusion Systems, one of the segments analyzed in the report, is projected to record 3.3% CAGR and reach US$608.5 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Cell Perfusion Systems segment is readjusted to a revised 4.1% CAGR for the next 8-year period.The U.S. Market is Estimated at $304.7 Million, While China is Forecast to Grow at 4% CAGR
The Perfusion Systems market in the U.S. is estimated at US$304.7 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$254.9 Million by the year 2030 trailing a CAGR of 4% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.9% and 3.6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.Select Competitors (Total 44 Featured) -
- ALA Scientific Instruments, Inc.
- Getinge AB
- Harvard Bioscience, Inc.
- Lifeline Scientific, Inc.
- LivaNova PLC
- Medtronic PLC
- Merck KgaA
- Nipro Corporation
- Repligen Corporation
- Spectrum Laboratories, Inc.
- Terumo Corporation
- Xenios AG
- XVIVO Perfusion AB
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIV. COMPETITION
1. MARKET OVERVIEW
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- ALA Scientific Instruments, Inc.
- Getinge AB
- Harvard Bioscience, Inc.
- Lifeline Scientific, Inc.
- LivaNova PLC
- Medtronic PLC
- Merck KgaA
- Nipro Corporation
- Repligen Corporation
- Spectrum Laboratories, Inc.
- Terumo Corporation
- Xenios AG
- XVIVO Perfusion AB
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 193 |
Published | April 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 1 Billion |
Forecasted Market Value ( USD | $ 1.5 Billion |
Compound Annual Growth Rate | 5.2% |
Regions Covered | Global |